
Divided US Supreme Court rules to let states cut Medicaid funding to Planned Parenthood
A divided Supreme Court allowed states to cut off Medicaid money to Planned Parenthood in a ruling handed down Thursday amid a wider Republican-backed push to defund the country's biggest abortion provider.
The case centers on funding for other health care services Planned Parenthood provides in South Carolina, but the ruling could have broader implications for Medicaid patients.
The court split 6-3 in the opinion, with the three liberal justices dissenting.
Public health care money generally can't be used to pay for abortions. Medicaid patients go to Planned Parenthood for things like contraception, cancer screenings and pregnancy testing, in part because it can be tough to find a doctor who takes the publicly funded insurance, the organization has said.
South Carolina's Republican governor says no taxpayer money should go the organization. The budget bill backed by President Donald Trump in Congress would also cut Medicaid funding to Planned Parenthood. That could force the closure of about 200 centers, most of them in states where abortion is legal, the organization has said.
Gov. Henry McMaster first moved to cut off Medicaid funding to Planned Parenthood in 2018 but was blocked in court after a lawsuit from a patient named Julie Edwards. Edwards wanted to keep going there for birth control because her diabetes makes pregnancy potentially dangerous, so she sued over a provision in Medicaid law that allows patients to choose their own qualified provider.
South Carolina, though, argued that patients shouldn't be able to file those lawsuits. The state pointed to lower courts that have been swayed by similar arguments and allowed states such as Texas to block Medicaid funding from Planned Parenthood.
Public health groups like the American Cancer Society, by contrast, said in court papers that lawsuits are the only real way that Medicaid patients have been able to enforce their right to choose their own doctor. Losing that right would reduce access to health care for people on the program, which is estimated to include one-quarter of everyone in the country. Rural areas could be especially affected, advocates said in court papers.
In South Carolina, $90,000 in Medicaid funding goes to Planned Parenthood every year, a tiny fraction of the state's total Medicaid spending. The state banned abortion at about six weeks' gestation after the high court overturned it as a nationwide right in 2022.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Indian Express
22 minutes ago
- New Indian Express
Market surges 15% from April lows, edges closer to peak levels
Defying tariff and geopolitical tensions, India's equity benchmarks, the BSE Sensex and NSE Nifty, have surged nearly 15% each from their early-April lows and are now approaching record highs. Extending gains for the third consecutive session on Thursday, the Sensex jumped 1,000.36 points (1.21%) to close at 83,755.87, while the Nifty50 rose 304.25 points (1.21%) to settle at 25,549.00. The Sensex now sits just 2,200 points shy of its all-time high of 85,978, and the Nifty is within 730 points of its peak (26,277). The market had nosedived between late March and early April after U.S. President Donald Trump announced a reciprocal tax on goods imported into the world's largest economy. The move stoked fears of an all-out global trade war, with retaliatory tariffs announced by China, the EU, and others. On April 7, the Sensex had plunged about 4,000 points intraday to hit a 52-week low of 71,725 and the Nifty 50 tumbled 1,150 points to hit a low of 21,744.


Time of India
27 minutes ago
- Time of India
'Just the beginning': Vivek Ramaswamy breaks record in raising fund for Guv election campaign, $8.5 million in five months
Vivek Ramaswamy breaks record in raising fund for Ohio Governor election which will be held in November 2026. Vivek Ramaswamy has raised over $8.5 million since his announcement of Ohio Governor election bid from the Republican party following his exit from the Department of Government Efficiency. Axios reported that this much money this early in the election cycle with the primary nearly a full year away is record-breaking. For comparison, Axios reported that Gov. Mike DeWine raised $3 million in the first half of 2021 during his reelection campaign. This money does not include any personal financing from Ramaswamy who spent over $30 million of his own money to fund his presidential campaign which he withdrew to support Donald Trump. "Just the beginning of breaking records in Ohio," Vivek reacted to his fund news. What is Vivek Ramaswamy's net worth? What is his source of wealth? Vivek Ramaswamy's net worth in 2025 is estimated to be between $800 million and $1.1 billion, with most sources leaning toward the higher end, around $1 billion. His wealth primarily comes from his 7-11% stake in Roivant Sciences, a biotech company he founded in 2014, valued at over $840 million based on SEC filings and campaign disclosures. Additional wealth stems from his stake in Strive Asset Management (worth over $100 million), investments in stocks, bonds, cryptocurrencies, and real estate, including two Ohio homes valued at $2.5 million. How did Indian-origin Vivek Ramaswamy become so rich? Born in 1985 to Indian immigrant parents (his father was a General Electric engineer and attorney, his mother a psychiatrist), Ramaswamy grew up in the Cincinnati suburb of Evendale. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Trading CFD dengan Teknologi dan Kecepatan Lebih Baik IC Markets Mendaftar Undo He attended St. Xavier High School, graduating as valedictorian in 2003. With his early business acumen, Vivek while he was studying biology at Harvard co-founded a business, a tech startup that connected budding entrepreneurs with professional resources via the internet. The business was later sold to the Kauffman Foundation, a nonprofit that fosters entrepreneurs and education. After graduating from Harvard, Ramaswamy joined QVT Financial, a New York-based investment advisory firm and hedge fund manager. He also studied law at Yale University in the same batch as JD Vance. His work at QVT involved investing in biotech companies, which led to his interest in the development of new prescription drugs. Ramaswamy founded Roivant in 2014 to buy or license promising drugs that weren't a priority for their owners. Roivant would then take over the development process for the potential future medicine. The company organized its developing drugs into subsidiary companies that could be spun off into separate ventures or be sold. In 2015, Ramaswamy cashed out a piece of his Roivant stake, accounting for the majority of his nearly $37.1 million in capital gains on his tax return. A potential Alzheimer's Disease drug, called intepirdine, was the main drug under development at Axovant, a Roivant subsidiary that the company spun off in a 2015 initial public offering. The stock nearly doubled in price on the first day of trading, making the company worth nearly $3 billion. In 2021, Ramaswamy stepped down as CEO and chairman of Roivant as he pursued new ventures. Then he published his best-selling book 'Woke Inc'


Mint
28 minutes ago
- Mint
Senate Parliamentarian blocks key Medicaid cuts in Trump's tax bill, jeopardizing July 4 deadline
The Senate parliamentarian delivered a crucial setback to Republicans on Thursday, ruling that a core Medicaid provider tax overhaul in President Donald Trump's sweeping tax-and-spending bill violates Senate procedural rules. The provision, intended to save $250 billion by slashing state taxes on hospitals and health providers, was a linchpin in offsetting the bill's trillions in tax breaks, primarily benefiting corporations and wealthy Americans. With Democrats uniformly opposed, Republican leaders must now scramble to revise or remove the provision entirely, as defying the nonpartisan parliamentarian's guidance is virtually unprecedented. The ruling intensifies pressure on GOP senators racing against Trump's July 4 deadline for passage, with the bill's fate now hanging in the balance. The fallout extends beyond Medicaid: The parliamentarian also rejected GOP measures blocking immigrants from healthcare programs and restricting gender-affirming care under Medicaid, further eroding the bill's planned savings. Republican leaders had leaned heavily on these health cuts to fund permanent extensions of Trump's 2017 tax cuts, which expire this year. Senate Finance Chair Ron Wyden (D-OR) hailed the rulings as a victory, stating they excised 'morally bankrupt' cuts threatening vulnerable Americans. Yet for Republicans, the decisions risk ballooning the bill's deficit impact, which the Congressional Budget Office already estimated at $2.8–$3.4 trillion over a decade. Even before the parliamentarian's ruling, the Medicaid cuts faced fierce resistance within the GOP. Senators Josh Hawley (R-MO), Susan Collins (R-ME), and Thom Tillis (R-NC) warned the provider tax reductions would cripple rural hospitals reliant on those funds—potentially triggering closures in their states. Hawley revealed Trump personally directed him late Wednesday to revert to the House's milder approach (freezing provider taxes instead of cutting them), signaling disarray in Republican strategy. Hospital associations nationwide echoed alarms, predicting the Senate's deeper cuts would 'wipe out balance sheets' and devastate healthcare access. To placate critics, Senate GOP leaders floated a $15 billion rural hospital fund as a safety net. But Collins demanded at least $100 billion, calling the initial figure woefully inadequate, while fiscal hawks like Sen. Rick Scott (R-FL) deemed even $15 billion excessive. Tillis, facing reelection in battleground North Carolina, bluntly warned colleagues the cuts could cost Republicans the 2026 midterms, comparing the political fallout to Democrats' Obamacare implosion in 2014. Meanwhile, House Republicans from New York and California threatened to sink the bill over unrelated state tax (SALT) disputes, highlighting the fragile coalition. With the parliamentarian's decision constraining GOP options, Republican leaders now face three untenable choices: strip the Medicaid provisions, revise them to comply with rules (a complex task under time pressure), or force a floor vote requiring 60 senators to override objections, a near-impossible threshold given Democratic unity. The ruling also undermines Trump's ultimatum for passage by July 4, though Majority Leader John Thune (R-SD) insisted Republicans have 'contingency plans' and are 'plowing forward.' Treasury Secretary Scott Bessent added urgency by noting the U.S. is nearing its debt limit deadline in August, complicating the timeline further. As the Senate grinds toward potential weekend votes, human stakes underscore the policy clash. In Missouri, mother Courtney Leader told CNN her 9-year-old daughter with cerebral palsy relies on Medicaid for life-sustaining care: 'Without Medicaid, we would lose everything, our home, our vehicles, and eventually, our daughter.'